BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19933801)

  • 1. Intrapulmonary pharmacokinetics of S-013420, a novel bicyclolide antibacterial, in healthy Japanese subjects.
    Furuie H; Saisho Y; Yoshikawa T; Shimada J
    Antimicrob Agents Chemother; 2010 Feb; 54(2):866-70. PubMed ID: 19933801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of EDP-420 after ascending single oral doses in healthy adult volunteers.
    Jiang LJ; Wang M; Or YS
    Antimicrob Agents Chemother; 2009 May; 53(5):1786-92. PubMed ID: 19223626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Friedland HD; Bhatia A
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Yeole R; Patel A; Bhatia A
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects.
    Gotfried MH; Horn K; Garrity-Ryan L; Villano S; Tzanis E; Chitra S; Manley A; Tanaka SK; Rodvold KA
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects.
    Rodvold KA; Gotfried MH; Still JG; Clark K; Fernandes P
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5076-81. PubMed ID: 22802254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Isaacs RD; O'Donnell JP; Stone E
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem.
    Conte JE; Golden JA; Kelley MG; Zurlinden E
    Int J Antimicrob Agents; 2005 Dec; 26(6):449-56. PubMed ID: 16280244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers.
    Housman ST; Pope JS; Russomanno J; Salerno E; Shore E; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2012 May; 56(5):2627-34. PubMed ID: 22330925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Gupta V; Ek A; Srivastava P; Talley A; Bruss J
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0059022. PubMed ID: 35762796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin.
    Conte JE; Golden JA; Kipps J; Zurlinden E
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3508-15. PubMed ID: 15328118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
    Conte JE; Golden JA; McIver M; Little E; Zurlinden E
    Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects.
    Wenzler E; Gotfried MH; Loutit JS; Durso S; Griffith DC; Dudley MN; Rodvold KA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7232-9. PubMed ID: 26349830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
    Togami K; Chono S; Morimoto K
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of GSK1322322 into epithelial lining fluid and alveolar macrophages as determined by bronchoalveolar lavage.
    Naderer OJ; Rodvold KA; Jones LS; Zhu JZ; Bowen CL; Chen L; Dumont E
    Antimicrob Agents Chemother; 2014; 58(1):419-23. PubMed ID: 24189245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.
    Andrews J; Honeybourne D; Ashby J; Jevons G; Fraise A; Fry P; Warrington S; Hawser S; Wise R
    J Antimicrob Chemother; 2007 Sep; 60(3):677-80. PubMed ID: 17623694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects.
    Rodvold KA; Bader J; Bruss JB; Hamed K
    Antimicrob Agents Chemother; 2023 Jul; 67(7):e0042623. PubMed ID: 37338378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapulmonary pharmacokinetics of linezolid.
    Conte JE; Golden JA; Kipps J; Zurlinden E
    Antimicrob Agents Chemother; 2002 May; 46(5):1475-80. PubMed ID: 11959585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intrapulmonary Pharmacokinetics and Drug Distribution Characteristics for the Treatment of Respiratory Diseases].
    Togami K
    Yakugaku Zasshi; 2020; 140(3):345-354. PubMed ID: 32115551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.